PhenoNet, Inc.
Overview
PhenoNet is a clinical-stage biotechnology company developing next-generation therapies for Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s Disease (AD), and related neurodegenerative disorders.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to PhenoNet, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Verified Supplier Partner
Is this PhenoNet, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
3D Imaging Drug Design and Development LLC
United States
A&B Pharmaceuticals
United States
Alexion Pharmaceuticals, Inc.
United States
BioPharma, Inc.
United States
Celerion, Inc.
United States
Charles River Laboratories International, Inc.
United States
Fortrea Holdings Inc.
United States
MediciNova, Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.